Printer Friendly

Navamedic to distribute Pohl-Boskamp's NYDA head lice remedy.

M2 PHARMA-December 7, 2010-Navamedic to distribute Pohl-Boskamp's NYDA head lice remedy(C)2010 M2 COMMUNICATIONS

7 December 2010 - Norwegian speciality pharma company Navamedic ASA (OSL: NAVA) said yesterday that its subsidiary Vitaflo Scandinavia will exclusively distribute the head lice remedy NYDA of German Pohl-Boskamp in Norway, Sweden and Denmark.

Navamedic added that the market for the product in these territories is estimated at about SEK18m (USD2.6m/EUR2m) a year.

The active ingredients in the product penetrate the airways of both the lice and its eggs and cause their suffocation. Navamedic's CEO Olof Milveden said that the product is recommended by the Swedish pharmaceutical authority.

(SEK1 = USD0.146/EUR0.109)

((Comments on this story may be sent to

COPYRIGHT 2010 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2010 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 Pharma
Geographic Code:4EXNO
Date:Dec 7, 2010
Previous Article:PAREXEL opens clinical logistics sites in Singapore and Russia.
Next Article:SinoFresh Healthcare acquires SRS International.

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters